Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million
04/10/2024 22:10
Oct 4 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* HYLORIS PHARMACEUTICALS SA- HY 2024 REVENUES (ROYALTIES
AND
MILESTONES) INCREASED TO EUR 4,2 MILLION (+576 1 %)
Further company coverage: HYL.BR
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyloris Pharmaceuticals SA
See all newsBrief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million
Brief: Euronext Announces Quarterly Review Of BEL Family Indices